PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,384 Posts.
    lightbulb Created with Sketch. 6929

    Hi Oxxa,

    Apologies its taken me some time before I could look into this one for you, there is some material out there on the internet in regards to DOD and Chikungunya. There isn't much on the DOD and RRV as RRV seems to be mainly prevalent In Aussie and the South Pacific. But we know of similarities between the two conditions as numerous reports have mentioned.

    Below is an article that mentions the collaboration between DOD and the FDA and mentions Chikungunya.

    Also here is an extract in regards to the efforts of researching into this and other disease outbreaks:

    Chikungunya virus, dengue virus, Crimean Congo hemorrhagic fever virus, Lassa virus, Venezuelan equine encephalitis virus, Eastern equine encephalitis virus and many others are among the viruses for which USAMRIID is creating medical countermeasures for warfighter and public-health protection. All of these pathogens can be classified as creating emerging or re-emerging infectious diseases in people, and most originate in animals and cross over to people.1

    Article

    https://www.fda.gov/emergency-preparedness-and-response/mcm-regulatory-science/us-department-defense-and-fda-collaborate-help-speed-potential-countermeasures-ebola-and-other

    Reference
    1) https://dod.defense.gov/News/Article/Article/603556/

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.